Science

Francisco J. Esteva: The practical implications of HER2-Low and HER2-Ultralow breast cancer

Francisco J. Esteva/LinkedIn

Feb 27, 2025, 11:33

Francisco J. Esteva: The practical implications of HER2-Low and HER2-Ultralow breast cancer

Francisco J. Esteva, Chief of the Division of Hematology and Medical Oncology at Lenox Hill Hospital and a Professor of Medicine at the Zucker School of Medicine, shared an article by Kathy D. Miller, et al. on LinkedIn:

“Excited to share my latest podcast episode with Dr. Kathy Miller, where we discuss the practical implications of HER2-Low and HER2-Ultralow breast cancer.

We explore how these evolving classifications impact treatment decisions and patient care.

Listen here.

A must-listen for oncologists, surgeons, researchers, and anyone interested in the future of precision oncology!”

New Classification of HER2–Ultra-Low Breast Cancer: What Do We Need to Know?

Francisco J. Esteva: The practical implications of HER2-Low and HER2-Ultralow breast cancer

Breast Cancer cancer fight against cancer Francisco J. Esteva global fight against cancerCancer Hematology HER2 Kathy D. Miller Lenox Hill Hospital MedOnc OncoDaily Oncology Precision Oncology Zucker School of Medicine

Eric Abidal and Liver Cancer: How He Returned to Football After Overcoming Illness

April is Head and Neck Cancer Awareness Month

Is Cancer Hereditary? Myths and Facts about Cancer Genetics

Neuroendocrine Lung Tumors: Types, Symptoms, Diagnosis, Treatment and 2025 updates

Cancer Center Near Me: Dana-Farber Cancer Institute